Chinese CDC investigators collected 923 environmental samples at the Huanan market beginning after its closure on January 1, 2020, and detected SARS-CoV-2 in 74 of them.

The custodian's own peer-reviewed paper gives 74 positives of 923 in the 2024 version of record, with the post-closure chronology and disinfection regime stated (COV-E004). The abstract/results discrepancy on animal-sampling dates is noted and does not touch this count.

Reported in the custodian's own peer-reviewed paper with sampling chronology and disinfection regime stated; the 2024 version of record gives 74 (COV-E004). The post-closure timing bears on COV-C007, not on this count.

Reported in the custodian's peer-reviewed paper with sampling chronology and disinfection regime stated; the 2024 version of record gives 74 (COV-E004). The post-closure timing constrains COV-C007, not this count.

The Chinese CDC's own peer-reviewed surveillance documented 74 SARS-CoV-2 positive results out of 923 environmental samples taken from the market. This firmly establishes the widespread presence of the virus on market surfaces. The strongest opposing consideration is that sampling commenced only after the market had been cleared and heavily disinfected, bounding what the sampling could detect and preventing determination of who or what originally deposited the RNA.

The Chinese CDC's peer-reviewed surveillance paper confirms 923 environmental samples were collected following the market's closure, with 74 returning positive for SARS-CoV-2. The data points are explicitly documented and universally recognized. The primary limitation is that sampling commenced only after the market was emptied and being disinfected, severely bounding the diagnostic value of the swabs.

The Chinese CDC's surveillance paper directly reports the collection of 923 environmental samples and the detection of 74 positives following the market's closure. This robustly establishes the presence of the virus throughout the market environment. The strongest opposing consideration is that sampling only commenced after the market was cleared of goods and disinfected, severely bounding the diagnostic value of the results.

COV-E004, from the Chinese CDC Nature paper, reports 923 post-closure environmental samples with 74 positives and describes the sampling timeline starting 1 January 2020; this directly supports the claim. The strongest limitation is that sampling began only after the market was closed, cleared, and under disinfection, which constrains what those 74 positives can tell us about pre-closure contamination.

The Chinese CDC surveillance paper reports that, starting 1 January 2020 after market closure, 923 environmental samples were collected and 74 tested positive for SARS‑CoV‑2 RNA (COV-E004), and no source contradicts these counts. The main limitation is that sampling began post‑closure amid ongoing disinfection, which affects interpretability but not the factuality of the numbers.

The Chinese CDC Nature paper gives precise counts and timing: 923 environmental samples taken after market closure with 74 testing positive for SARS‑CoV‑2. The limitation, which weakens its probative value, is that all sampling occurred after the market had been cleared and was being disinfected, so the observation says little about who or what originally shed virus there.

Liu 2024, the version of record, reports 923 environmental samples collected from 1 January 2020 after morning closure and SARS-CoV-2 detection in 74 of them (70 by RT-qPCR and 4 by Bowtie2), with the count updated from 73 by a note added in proof. The sampling chronology is explicit in the same paper. The strongest opposing consideration is interpretive rather than metrical: sampling began only after the market was emptied and stall surfaces and goods were being disinfected through January and February, so environmental RNA cannot identify who deposited it — an infected vendor, a customer, or an animal all produce the same swab.

Liu et al., the Chinese CDC surveillance paper, report that 923 environmental samples were collected from 1 January 2020 after the market closed that morning and that SARS-CoV-2 was detected in 74 of them (70 by RT-qPCR and 4 by Bowtie2). The 2024 version of record is the figure to use; the accelerated preview had 73 before a note added in proof. Sampling after clearance and ongoing disinfection bounds what the swabs can mean, but that is interpretation, not a dispute about the counts. Strongest opposing consideration: the paper is produced by the custodian whose data-sharing is itself in dispute, and a dating inconsistency between abstract and Results on when animal sampling began is noted rather than resolved.

The Chinese CDC surveillance paper states that 923 environmental samples were collected from 1 January 2020 after market closure and that SARS-CoV-2 was detected in 74 of them, with the version of record correcting an earlier preview count of 73. The same paper records that sampling began the day the market closed and that stall surfaces and goods were disinfected through January and February, which bounds what the swabs could still detect. The strongest opposing consideration is that the counts come from the custodian whose data-sharing is itself in dispute, and environmental RNA cannot identify whether an animal, a vendor, or a customer deposited it.

The counts and chronology are stated in the custodian's own peer-reviewed paper: 923 environmental samples collected from January 1, 2020, with 74 positive in the 2024 version of record, sampling beginning only after closure. The observation is not meaningfully disputed by any party. The strongest opposing consideration bears on interpretation rather than truth: the market had been cleared and was being disinfected throughout the collection period, so the measurement is real but bounded before it began — and it is the interpretation, not the count, that is contested. Verdict follows the statement as written.

The counts and chronology are verified verbatim from the 2024 version of record: 923 environmental samples collected from January 1, 2020, 74 positive, with the 73-to-74 change between preview and version of record explained by a note in proof. No party in the record contests the numbers, and an overlapping team reanalyzed the underlying raw reads without disputing them. The strongest opposing consideration is that the data are custodian-produced and the market was cleared and disinfected during collection — but that bounds interpretation, which the claim deliberately does not assert. This is the least interpretive item in the theme and earns the strongest grade.

The sampling chronology and the 74-positive count are stated in the custodian's own peer-reviewed paper, with the 73-to-74 correction transparently explained by a note in proof. As a measurement claim it is secure. The strongest opposing consideration bears on meaning, not fact: sampling began only after the market was cleared and disinfection was underway, so the result is compatible with every hypothesis in the case and cannot identify the depositor. I would flag that the source is the party whose data-sharing is disputed, but nothing in the record contradicts the counts.

A straightforward reported measurement in the Chinese CDC's own peer-reviewed paper, with sampling chronology stated explicitly, and not disputed by any party in the case. The only wobble is the 73-to-74 change between the 2023 accelerated preview and the 2024 version of record, explained by a note added in proof. The strongest opposing consideration is custodial: the numbers cannot be independently audited, and the same paper records that stalls and goods were disinfected through January and February 2020, which bounds what the sampling could have detected — but that bears on interpretation, not on whether the counts are as reported.

The counts, the sampling chronology, and the disinfection timeline are all verbatim in the Chinese CDC's peer-reviewed version of record. The strongest opposing consideration is provenance: this is the custodian reporting on its own investigation, with no independent verification of collection, chain of custody, or assay results, and the paper carries internal inconsistencies (73 versus 74 positives across versions; conflicting sampling start dates between abstract and Results). Those blemishes affect precision rather than the substance of the measurement. The measurement itself is close to uninterpretable for origins, which is a separate matter from whether it is true.

The counts are stated verbatim in the Chinese CDC's own peer-reviewed paper, with the sampling chronology explicit, and the 73-versus-74 discrepancy between preview and version of record is documented rather than papered over. Outside groups have worked with the underlying sequencing data, which is a partial independent check on the dataset's existence and structure. The strongest opposing consideration is that this is a single-custodian measurement produced by the party whose data-sharing is itself in dispute, and no one has audited the collection log; that is why I withhold "established." The measurement is also close to non-diagnostic on its own, since environmental RNA cannot identify the depositor.

Reported in the custodian's own peer-reviewed paper with the sampling chronology and disinfection regime stated; cite the 2024 version of record, where the count is 74.

Reported in the custodian's own peer-reviewed paper with the sampling chronology and disinfection regime stated (COV-E004); the 2024 version of record gives 74. Grok correctly stresses that the post-closure timing is itself a limitation on COV-C007, not on this count.